Circulating melatonin and the risk of breast and endometrial cancer in women.
about
Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study IIUrinary melatonin and risk of ovarian cancerThe circadian clock in cancer development and therapyShift work: health, performance and safety problems, traditional countermeasures, and innovative management strategies to reduce circadian misalignmentmiR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice.Xenobiotic metabolism: a view through the metabolometer.Effects of physical activity on melatonin levels in previously sedentary men and womenUrinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes.Circadian gene variants in cancer.Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer.Extended exposure to dietary melatonin reduces tumor number and size in aged male mice.Sleep duration and breast cancer risk: a meta-analysis of observational studies.Individual variations in serum melatonin levels through time: implications for epidemiologic studies.Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cellsMelatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growthChronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in ratsRecommendations for the prevention of breast cancer in shift workers.Sleep duration and incidence of colorectal cancer in postmenopausal womenThe Reduction in Circulating Melatonin Level May Contribute to the Pathogenesis of Ovarian Cancer: A Retrospective StudyThe role of circadian rhythm in breast cancerSymptoms of sleep disordered breathing and risk of cancer: a prospective cohort study.Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implicationsFirst-morning urinary melatonin and breast cancer risk in the Guernsey StudyClock genes: their role in colorectal cancerExtracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration.Serum depletion induced cancer stem cell-like phenotype due to nitric oxide synthesis in oncogenic HRas transformed cells.Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort.Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling.The circadian rhythm in adult attention-deficit/hyperactivity disorder: current state of affairs.The impact of shiftwork on health: a literature review.Modeled traffic noise at the residence and colorectal cancer incidence: a cohort study.Sleep, Melatonin, and the Menopausal Transition: What Are the Links?Circadian disruption in experimental cancer processes.Exposure to road traffic and railway noise and postmenopausal breast cancer: A cohort study.Industry-based retrospective cohort study of the risk of prostate cancer among rotating-shift workers.Short-wavelength attenuated polychromatic white light during work at night: limited melatonin suppression without substantial decline of alertness.Associations between sleep characteristics, seasonal depressive symptoms, lifestyle, and ADHD symptoms in adults.Melatonin and Metformin Diminish Oxidative Stress in Heart Tissue in a Rat Model of High Fat Diet and Mammary Carcinogenesis.Sleep duration and endometrial cancer risk.
P2860
Q23921999-9DEB9630-CB11-470F-8B23-EFBA6FEA5873Q28388517-EB008618-37F2-450B-88CE-3FF7F082B23DQ28390451-B78A4CB6-4550-40AE-98A5-E9F8BBE8B020Q28397062-501C2C18-303E-43D0-9D81-F9F6DBF86D14Q30760000-DDE2F143-7825-44E5-A607-23ED09F798CAQ33601559-6ADD5710-DCD7-4985-B20D-4C44FF1F4905Q33857577-1532089E-A699-49C6-A571-1EF14D87ECF3Q33992178-AED23759-37B7-4DBD-8F10-0EB929CBCD72Q34029266-90686E22-8ACC-4950-9DDB-692F2D624730Q34127839-9DD93E1E-EC58-4866-9446-633CAAAF9E31Q34168873-66E87E11-4C61-4310-A225-F20DFFC678EEQ34388391-F57AE504-91BE-42B8-B3F5-4845C0AA3F44Q34987717-C6CBA1DB-5312-4348-A68B-F4EDCF3E182CQ35077971-A4565B1A-0ED0-4AD2-829E-7485CFB3A218Q35172397-356665AA-2AC5-4B50-89E7-9B1630DCB93FQ35321923-6345E6AD-75D4-40E5-8B88-57D2EBD63AF6Q35803377-963C1F70-CEF4-4421-B876-5F5FE1A60F61Q36117976-E0CFD19E-8CD9-496A-9B52-4869195B84B0Q36557911-C40D39E8-1313-481F-AA68-49E738EA60DAQ36882589-77BF68B3-D4F2-4934-A105-DE4D0185BC2DQ37118219-C1AF6D7F-BFDE-4FC6-BB2F-00025A9BD0B9Q37171128-D4D6CC44-6A86-4C6E-B1B1-340192D0A564Q37525906-13810028-A6ED-47B6-A1F7-19A9AB2B1CFFQ37591161-3C241901-F7EB-456A-8FFC-6BF2EDFA7FD2Q37602726-EBA786D2-C9C2-47AF-B288-B507A96B0BABQ37652212-1CD2D8CD-E2AB-4D05-973E-40897726234FQ37688926-C6FC5B4C-187F-45EE-A47D-C4C431D1DD91Q37701138-DDFBB5C0-A360-4864-B75E-9E1F601AE303Q37950409-9968B489-D111-42BC-BCE0-6C1F4A2E0A89Q38151773-6DD79A7F-13A5-4400-9A57-DD95C42093A7Q38181606-522F1113-5854-45B3-A5E7-51B617CB14B3Q40197452-9675AF0A-2D75-4A2F-906B-3D8C3B9ACD0DQ41668985-505A99F0-75C4-4003-BA7C-C60E008E3EAAQ43204662-B1D19E31-1BDF-4425-8447-89F0E14014C4Q43457861-A264E75D-6848-485F-A9E6-20093F2014DDQ44085986-9E6B7F8F-E8F5-4F45-AC21-27368031D49AQ44112190-0058FCA3-8DFC-44AC-B237-543CAD1D81A7Q45800750-56F2B707-2E7E-439E-B9D3-059B24DF7BAFQ46259060-47CB42C1-A4C7-4477-A7E3-20D2F39E5B8EQ46972291-7BE407CA-FD2B-4E45-810B-7E0D8F07FC73
P2860
Circulating melatonin and the risk of breast and endometrial cancer in women.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating melatonin and the risk of breast and endometrial cancer in women.
@en
Circulating melatonin and the risk of breast and endometrial cancer in women.
@nl
type
label
Circulating melatonin and the risk of breast and endometrial cancer in women.
@en
Circulating melatonin and the risk of breast and endometrial cancer in women.
@nl
prefLabel
Circulating melatonin and the risk of breast and endometrial cancer in women.
@en
Circulating melatonin and the risk of breast and endometrial cancer in women.
@nl
P2860
P1433
P1476
Circulating melatonin and the risk of breast and endometrial cancer in women
@en
P2093
Akila N Viswanathan
Eva S Schernhammer
P2860
P356
10.1016/J.CANLET.2008.11.002
P407
P577
2008-12-12T00:00:00Z